Literature DB >> 33148669

Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.

Jeremiah Holt1, Vonn Walter2, Xiaoying Yin3, David Marron4, Matthew D Wilkerson4, Hyo Young Choi1, Xiaobei Zhao1, Heejoon Jo1, David Neil Hayes5, Yoon Ho Ko6.   

Abstract

PURPOSE: The objective of this study is to characterize the role of miRNAs in the classification of head and neck squamous cell carcinoma (HNSCC). EXPERIMENTAL
DESIGN: Here, we analyzed 562 HNSCC samples, 88 from a novel cohort and 474 from The Cancer Genome Atlas, using miRNA microarray and miRNA sequencing, respectively. Using an integrative correlations method followed by miRNA expression-based hierarchical clustering, we validated miRNA clusters across cohorts. Evaluation of clusters by logistic regression and gene ontology approaches revealed subtype-based clinical and biological characteristics.
RESULTS: We identified two independently validated and statistically significant (P < 0.01) tumor subtypes and named them "epithelial" and "stromal" based on associations with functional target gene ontology relating to differing stages of epithelial cell differentiation. miRNA-based subtypes were correlated with individual gene expression targets based on miRNA seed sequences, as well as with miRNA families and clusters including the miR-17 and miR-200 families. These correlated genes defined pathways relevant to normal squamous cell function and pathophysiology. miRNA clusters statistically associated with differential mutation patterns including higher proportions of TP53 mutations in the stromal class and higher NSD1 and HRAS mutation frequencies in the epithelial class. miRNA classes correlated with previously reported gene expression subtypes, clinical characteristics, and clinical outcomes in a multivariate Cox proportional hazards model with stromal patients demonstrating worse prognoses (HR, 1.5646; P = 0.006).
CONCLUSIONS: We report a reproducible classification of HNSCC based on miRNA that associates with known pathologically altered pathways and mutations of squamous tumors and is clinically relevant. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33148669      PMCID: PMC7854517          DOI: 10.1158/1078-0432.CCR-20-0557

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   13.801


  57 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Tumorigenicity of the miR-17-92 cluster distilled.

Authors:  Gijs van Haaften; Reuven Agami
Journal:  Genes Dev       Date:  2010-01-01       Impact factor: 11.361

3.  Molecular signatures database (MSigDB) 3.0.

Authors:  Arthur Liberzon; Aravind Subramanian; Reid Pinchback; Helga Thorvaldsdóttir; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2011-05-05       Impact factor: 6.937

4.  A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs.

Authors:  Tae-Min Kim; Wei Huang; Richard Park; Peter J Park; Mark D Johnson
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

5.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

6.  Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.

Authors:  Michaela K Keck; Zhixiang Zuo; Arun Khattri; Thomas P Stricker; Christopher D Brown; Matin Imanguli; Damian Rieke; Katharina Endhardt; Petra Fang; Johannes Brägelmann; Rebecca DeBoer; Mohamed El-Dinali; Serdal Aktolga; Zhengdeng Lei; Patrick Tan; Steve G Rozen; Ravi Salgia; Ralph R Weichselbaum; Mark W Lingen; Michael D Story; K Kian Ang; Ezra E W Cohen; Kevin P White; Everett E Vokes; Tanguy Y Seiwert
Journal:  Clin Cancer Res       Date:  2014-12-09       Impact factor: 12.531

7.  Human papillomavirus 16 E5 modulates the expression of host microRNAs.

Authors:  Dario Greco; Niina Kivi; Kui Qian; Suvi-Katri Leivonen; Petri Auvinen; Eeva Auvinen
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

8.  Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients.

Authors:  Giuseppina Della Vittoria Scarpati; Enrica Calura; Mariacristina Di Marino; Chiara Romualdi; Luca Beltrame; Umberto Malapelle; Giancarlo Troncone; Alfonso De Stefano; Stefano Pepe; Sabino De Placido; Maurizio D'Incalci; Sergio Marchini; Chiara Carlomagno
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

9.  Comprehensive genomic characterization of squamous cell lung cancers.

Authors: 
Journal:  Nature       Date:  2012-09-09       Impact factor: 49.962

10.  miRWalk: An online resource for prediction of microRNA binding sites.

Authors:  Carsten Sticht; Carolina De La Torre; Alisha Parveen; Norbert Gretz
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more
  4 in total

Review 1.  Biological roles and clinical significance of estrogen and androgen receptors in head and neck cancers.

Authors:  Chunhong Qin; Yan Lu; Huimin Zhang; Zhe Zhang; Wei Xu; Shuxin Wen; Wei Gao; Yongyan Wu
Journal:  J Cancer       Date:  2022-04-04       Impact factor: 4.478

2.  A Super-Enhancer Driven by FOSL1 Controls miR-21-5p Expression in Head and Neck Squamous Cell Carcinoma.

Authors:  Yuehan Wan; Rosalie G Hoyle; Nan Xie; Wenjin Wang; Hongshi Cai; Ming Zhang; Zhikun Ma; Gan Xiong; Xiuyun Xu; Zhengxian Huang; Xiqiang Liu; Jiong Li; Cheng Wang
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

Review 3.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

4.  miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker.

Authors:  Weronika Tomaszewska; Joanna Kozłowska-Masłoń; Dawid Baranowski; Anna Perkowska; Sandra Szałkowska; Urszula Kazimierczak; Patricia Severino; Katarzyna Lamperska; Tomasz Kolenda
Journal:  Biomedicines       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.